Laine Mello, director of Marketing at Ecolab for its bioprocessing business, shares her insights on the digital ...

Tariffs and significant US manufacturing investments complicate ROI calculations and increase operational costs, challenging ...

For much of the past decade, drug shortages in the United States were treated as episodic disruptions. In 2024, that framing ...

SK Capital Partners have signed a definitive agreement to divest the Noramco API related assets in a sale to Siegfried (Zofingen Switzerland) -- The transaction is subject to customary closing ...

SAN DIEGO, CA - January 27, 2026 (NEWMEDIAWIRE) - Quantumzyme Corp. (OTC: QTZM), a biotransformation company focused on sustainable pharmaceutical manufacturing, today announced a breakthrough ...

These three stocks stand out not only because of their relatively low valuations, but also because of promising growth ...

PMMI research identifies top manufacturing hurdles including regulatory compliance, automation needs, and sustainability priorities ...

PMMI research shows pharmaceutical manufacturers face a growing market and will need OEMs and suppliers to overcome ...

Stakeholders said regulatory alignment, safeguards against unfair competition, and how patient safety is protected will ...

Regulatory authorities in China have cracked down on Sun Pharma’s rivastigmine-based Alzheimer’s disease treatment, halting ...

EMVision Medical Devices and Clever Culture Systems are among ASX healthcare companies reporting milestones reached in ...

Siegfried, a global CDMO for the pharmaceutical industry, has signed binding agreements with an affiliate of SK Capital ...